To assess the prevalence and potential indications of PDE5 inhibitor use among pregnant and reproductive‐age women in the United States. Click to show full abstract
To assess the prevalence and potential indications of PDE5 inhibitor use among pregnant and reproductive‐age women in the United States.
               
Click one of the above tabs to view related content.